Tag Archives: Spinraza

Health Insurance, Pharmacy Benefit Managers, Rare/Orphan Disease

Aetna Launches New Network to Cover New Gene Therapies for Rare Diseases

Posted on by John Santilli
08
Nov

Aetna recently announced an initiative to launch a designated network to cover new gene therapies for rare diseases. This follows an initiative by CVS Health in 2019 to provide self-insured employers with a stop-loss program with Aetna health plans and cover gene therapies

Continue reading →
Specialty Drug, Specialty HUBs

CareMetx, LLC’s OutcomeRx Launches a Reinsurance Product for Cell and Gene Therapies

Posted on by John Santilli
20
Nov

OutcomeRx focuses on engaging with biotech companies to think through, structure, and manage value-based agreements

Continue reading →
Specialty Drug, Specialty Pharmacy

Programs Covering the Cost of Gene Therapies Increase

Posted on by John Santilli
13
May

Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers

Continue reading →